1. Home
  2.  » 
  3. Expert Content
  4.  » Zydis® ODT Consistently Offers Effective Solutions for Sublingual Allergy Immunotherapy

Zydis® ODT Consistently Offers Effective Solutions for Sublingual Allergy Immunotherapy

Summary: ALK-Abelló A/S is a Denmark-based pharmaceutical company that specializes in the development of immunotherapy products for the treatment of respiratory allergies. ALK partnered with Catalent for the formulation, development and manufacturing of their sublingual immunotherapy (SLIT) tablets utilizing the Zydis® orally disintegrating tablet (ODT) platform.

Download the case study to learn how ALK and Catalent collaborated to develop a sublingually administered immunotherapy tablet, which provided a more convenient treatment option for the patients. 

Click here to download case study.